The absence of mitochondrial oxidative phosphorylation in cancer cells may provide them with survival advantages; this results in an increase in NADH levels, which results the inactivation of PTEN through a redox modification mechanism and activation of the Atk survival pathway, which provides cancer cells with drug resistance and improved ability to survive during hypoxia (Pelicano et al., 2006). Here, BTK is linked to cancer.